Overview
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Aug 30, 2010 | Funding round | $15M | |
| Jan 8, 2009 | Funding round | $30M |
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 23, 2021 | Aptus Capital Advisors Launches the International Drawdown-Managed Equity ETF (CBOE: IDME) as Aptus ETFs Crosses $1.3B in Assets | Aptus Capital Advisors, LLC announces the launch of the International Drawdown-Managed Equity ETF (Cboe: IDME), an actively-managed exchange-traded fund (ETF) targeting non-U.S. stocks with a focus on managing drawdown risk through hedges. ... |
| Sep 10, 2019 | Aptus raises Rs 880 cr from Steadview Capital, Sequoia, Malabar Investments | |
| Sep 10, 2019 | Aptus Value Housing Fin raises ₹880 cr | Aptus Value Housing Finance, which lends to low-income people for their housing needs, has secured about ₹880 crore in equity, as the Chennai-headquartered company gears up for the next growth curve. This ₹880-crore raise was led by the exi... |
| Jan 16, 2018 | Aptus Value receives ₹270 cr as private equity investment | Aptus Value Housing Finance, which has received private equity investment of ₹270 crore, is rapidly expanding its network in the South. M Anandan, Chairman and Managing Director, Aptus Value, said the investment received includes ₹ 245 cror... |
| Jun 28, 2012 | Aptus Endosystems Closes $25M Equity Financing | Aptus Endosystems, a Sunnyvale, Calif.-based company that develops technology for endovascular aneurysm repair, has closed a $25m equity financing. The round was led by Synergy Life Science Partners, with participation from existing investo... |
| Jun 28, 2012 | Aptus Endosystems Completes $25M Series BB | SUNNYVALE, CA, Medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced closing on $25 million of equity financing. >> Click here for more funding data on Aptus Endosystems >> ... |
| Nov 27, 2010 | Clinical Update: A gap in the FDA’s oversight of medical device trials | There’s a “potentially troubling gap” in the Food & Drug Administration’s oversight of medical device clinical trials, according to the Wall Street Journal — the federal watchdog agency doesn’t inspect device-making plants during trials... |
| Nov 27, 2010 | ‘Potential troubling gap’ in FDA’s oversight of med device trials | There’s a “potentially troubling gap” in the Food & Drug Administration’s oversight of medical device clinical trials, according to the Wall Street Journal — the federal watchdog agency doesn’t inspect device-making plants during trials... |
| Aug 30, 2010 | Aptus Endosystems Completes $15M Series “AA” Financing | Aptus Endosystems, Inc., a Sunnyvale, CA-based medical device company developing advanced technology for endovascular aneurysm repair (EVAR), completed a $15m Series “AA” financing. The round was led by U.S. Venture Partners and Longitude C... |
Reviews 0
FAQ about Aptus
When was Aptus founded?
Aptus was founded in 2002.
How much funding has Aptus raised?
Aptus has raised $70M in total across 3 funding rounds.
What funding rounds has Aptus raised?
Parsers VC lists 3 funding rounds of Aptus, among them a funding round of $15M on Aug 30, 2010 and a funding round of $30M on Jan 8, 2009.
What has the press written about Aptus?
Parsers VC has collected 13 articles mentioning Aptus, among them “Aptus Capital Advisors Launches the International Drawdown-Managed Equity ETF (CBOE: IDME) as Aptus ETFs Crosses $1.3B in Assets” (Jul 23, 2021) and “Aptus raises Rs 880 cr from Steadview Capital, Sequoia, Malabar Investments” (Sep 10, 2019).
Is Aptus still active?
Aptus is probably closed: its latest activity on Parsers VC dates from Aug 10, 2021.